Attendees march past the Big Ben to the Downing Street on national day of reflection to mark the 1 year anniversary of The National Covid Memorial Wall creation, in London, Britain March 29, 2022. REUTERS
The British Medicines Control Agency authorized Novavax’s (NVAX.O) COVID-19 vaccination for youngsters aged 12 to 17 years old on Friday.
Moderna’s mRNA vaccines, as well as the Pfizer-BioNTech collaboration, have also been approved for use by this age range, according to the Medicines and Healthcare products Regulatory Agency (MHRA).
Novavax’s two-dose vaccination, Nuvaxovid, was approved for use in adults in the United Kingdom in February.
